Logo image of MBOT

MICROBOT MEDICAL INC (MBOT) Stock Fundamental Analysis

NASDAQ:MBOT - Nasdaq - US59503A2042 - Common Stock - Currency: USD

2.48  -0.02 (-0.8%)

After market: 2.4998 +0.02 (+0.8%)

Fundamental Rating

2

Taking everything into account, MBOT scores 2 out of 10 in our fundamental rating. MBOT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While MBOT has a great health rating, there are worries on its profitability. MBOT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

MBOT had negative earnings in the past year.
MBOT had a negative operating cash flow in the past year.
MBOT had negative earnings in each of the past 5 years.
In the past 5 years MBOT always reported negative operating cash flow.
MBOT Yearly Net Income VS EBIT VS OCF VS FCFMBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

MBOT has a Return On Assets of -37.79%. This is in the lower half of the industry: MBOT underperforms 62.23% of its industry peers.
With a Return On Equity value of -40.32%, MBOT perfoms like the industry average, outperforming 51.60% of the companies in the same industry.
Industry RankSector Rank
ROA -37.79%
ROE -40.32%
ROIC N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
MBOT Yearly ROA, ROE, ROICMBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

MBOT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBOT Yearly Profit, Operating, Gross MarginsMBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, MBOT has more shares outstanding
Compared to 5 years ago, MBOT has more shares outstanding
MBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBOT Yearly Shares OutstandingMBOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MBOT Yearly Total Debt VS Total AssetsMBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 23.68 indicates that MBOT is not in any danger for bankruptcy at the moment.
MBOT's Altman-Z score of 23.68 is amongst the best of the industry. MBOT outperforms 95.74% of its industry peers.
MBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 23.68
ROIC/WACCN/A
WACCN/A
MBOT Yearly LT Debt VS Equity VS FCFMBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 16.19 indicates that MBOT has no problem at all paying its short term obligations.
The Current ratio of MBOT (16.19) is better than 96.81% of its industry peers.
A Quick Ratio of 16.19 indicates that MBOT has no problem at all paying its short term obligations.
MBOT's Quick ratio of 16.19 is amongst the best of the industry. MBOT outperforms 97.87% of its industry peers.
Industry RankSector Rank
Current Ratio 16.19
Quick Ratio 16.19
MBOT Yearly Current Assets VS Current LiabilitesMBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.50% over the past year.
EPS 1Y (TTM)17.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.06%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y44.86%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MBOT Yearly Revenue VS EstimatesMBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2025 2M 4M 6M
MBOT Yearly EPS VS EstimatesMBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800

0

4. Valuation

4.1 Price/Earnings Ratio

MBOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MBOT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBOT Price Earnings VS Forward Price EarningsMBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBOT Per share dataMBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MBOT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MICROBOT MEDICAL INC

NASDAQ:MBOT (6/12/2025, 8:07:56 PM)

After market: 2.4998 +0.02 (+0.8%)

2.48

-0.02 (-0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-12 2025-08-12
Inst Owners7.48%
Inst Owner Change87.13%
Ins Owners1.47%
Ins Owner Change0%
Market Cap90.22M
Analysts82.86
Price Target9.18 (270.16%)
Short Float %18.62%
Short Ratio2.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.6%
Min EPS beat(2)-8.93%
Max EPS beat(2)32.13%
EPS beat(4)2
Avg EPS beat(4)2.45%
Min EPS beat(4)-15.34%
Max EPS beat(4)32.13%
EPS beat(8)6
Avg EPS beat(8)10.46%
EPS beat(12)9
Avg EPS beat(12)9.9%
EPS beat(16)11
Avg EPS beat(16)4.66%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25%
EPS NY rev (1m)0%
EPS NY rev (3m)23.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.12
P/tB 3.12
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0
BVpS0.8
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.79%
ROE -40.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.77%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.19
Quick Ratio 16.19
Altman-Z 23.68
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)46.2%
Cap/Depr(5y)70.94%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.06%
EPS Next Y44.86%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.95%
OCF growth 3YN/A
OCF growth 5YN/A